Tech Company Financing Transactions
Harness Therapeutics Funding Round
Harness Therapeutics secured a $22.2 million funding round on 11/28/2023. Investors included Takeda Ventures and Epidarex Capital.
Transaction Overview
Company Name
Announced On
11/28/2023
Transaction Type
Venture Equity
Amount
$22,240,000
Round
Undisclosed
Investors
Takeda Ventures (Lead Investor)
Proceeds Purpose
Proceeds will be used to advance Harness' lead Huntington's Disease (HD) programme targeting FAN1 nuclease and pursue target discovery and validation activities in other neurodegenerative disease pathways.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
30 Broad Street Great Cambourne
Cambridge, CB23 6HJ
UK
Cambridge, CB23 6HJ
UK
Phone
Undisclosed
Website
Email Address
Overview
Developer of a biotechnology platform designed to help the physiological upregulation of important, validated neurodegenerative targets. The company's platform offers unmet medical needs and builds differentiated products that cannot be generated with other technologies, enabling clients to boost the expression of almost any protein of choice by enhancing translation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jan Thirkettle
Chief Scientific Officer
Andy Billinton
Browse more venture capital transactions:
Prev: 11/28/2023: PayGround venture capital transaction
Next: 11/28/2023: PlantSwitch venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs